Relationship found between mild asthma and poor clinical outcome – addressing asthma

December 12th, 2017

The topic of mild asthma was addressed at the 60thAnnual Meeting of theAmerican College ofAllergy,Asthma and Immunology in SanAntonio, Texas.Asthma is a disease characterized by significant variability. Exposure to allergen or common viral respiratory tract infections may trigger an exacerbation. These flares of symptoms will respond to therapy or reverse spontaneously. Furthermore, there is a diurnal variation in the intensity of asthma reflecting time of day differences in mediator release and endogenous glucocorticoid and catecholamine levels. The 1997 National Heart, Lung, and Blood Institute (NHLBI) Guidelines for the Diagnosis and Management ofAsthma[1] established criteria for disease severity classification. Daytime symptoms for patients with mild persistent asthma occur more than twice a week but less than daily and for nighttime symptoms occur between 2 and 4 times a month. Does disease variability limit the applicability of this classification scheme? TheAgency for Healthcare Research and Quality (AHRQ) was contracted to perform the evidence-based review for the 2002 NHLBI guideline update. In their discussion of disease classification, theAHRQ stated that